Our findings help better understand the biological function of circMET in NONO-TFE3 tRCC pathogenesis and provide a rationale for RNA-based diagnosis and treatment in Xp11.2 tRCC and other human malignancies. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.